ST6GAL1 and non-small cell lung carcinoma: Increased expressions of ST3GAL4 (82), ST6GAL1 (80), and ST6GalNAc1 (81) were identified in most patients with NSCLC, and inhibiting these enzymes may suppress NSCLC cell metastasis.